Correlation Between Vigil Neuroscience and Connect Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Connect Biopharma Holdings, you can compare the effects of market volatilities on Vigil Neuroscience and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Connect Biopharma.

Diversification Opportunities for Vigil Neuroscience and Connect Biopharma

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Vigil and Connect is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Connect Biopharma go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Connect Biopharma

Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Connect Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Vigil Neuroscience is 1.22 times less risky than Connect Biopharma. The stock trades about -0.23 of its potential returns per unit of risk. The Connect Biopharma Holdings is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest  122.00  in Connect Biopharma Holdings on August 24, 2024 and sell it today you would lose (23.00) from holding Connect Biopharma Holdings or give up 18.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Vigil Neuroscience  vs.  Connect Biopharma Holdings

 Performance 
       Timeline  
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Connect Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Connect Biopharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Connect Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Vigil Neuroscience and Connect Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vigil Neuroscience and Connect Biopharma

The main advantage of trading using opposite Vigil Neuroscience and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.
The idea behind Vigil Neuroscience and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated